NOVAVAX INC (NVAX)       11.29  +0.31 (+2.82%)

11.29  +0.31 (+2.82%)

US6700024010 - Common Stock - Premarket: 11.19 -0.1 (-0.89%)

NOVAVAX INC11.29

NASDAQ:NVAX (1/27/2023, 7:25:13 PM)+0.31 (+2.82%)

Premarket: 11.19 -0.1 (-0.89%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-08 2022-11-08/amc Earnings (Next) 02-27 2023-02-27
Ins Owners 0.26% Inst Owners 43.82%
Market Cap 959.70M Shares 85.00M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 74.29
IPO 05-16 1973-05-16

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NVAX Daily chart

Company Profile

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. The company is headquartered in Gaithersburg, Maryland and currently employs 1,541 full-time employees. The firm promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).

Company Info

NOVAVAX INC

21 Firstfield Road

Gaithersburg MARYLAND 20878

P: 12402682000.0

CEO: Stanley C. Erck

Employees: 1541

Website: https://www.novavax.com/

NVAX News

News Image3 days ago - Investor's Business DailyNovavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip

The FDA's experts voted in favor of annual boosters on Thursday.

News Image3 days ago - The Motley Fool3 Great Growth Stocks Down 20% or More to Buy Now

These beaten-down stocks could be poised for major rebounds.

News Image4 days ago - Market News VideoNVAX March 10th Options Begin TradingNews Image5 days ago - Novavax, Inc.Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

News Image5 days ago - The Motley FoolThis Investment Strategy Would Have Reduced Your Novavax Losses by 20% Last Year

If you want to invest in volatile stocks, a certain strategy can minimize your overall risk.

News Image6 days ago - The Motley Fool3 Remarkable Stocks That Can Burn Short-Sellers Big-Time in 2023

Exceptionally high short interest in these innovative and transformative businesses may lead to a short squeeze.

NVAX Twits

Here you can normally see the latest stock twits on NVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example